Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
11.02
-0.37 (-3.25%)
At close: Oct 6, 2025, 4:00 PM EDT
10.90
-0.12 (-1.09%)
After-hours: Oct 6, 2025, 7:43 PM EDT
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $979.42 million as of October 6, 2025. Its market cap has increased by 96.51% in one year.
Market Cap
979.42M
Enterprise Value
1.02B
1-Year Change
96.51%
Ranking
Category
Stock Price
$11.02
Market Cap Chart
Since the IPO on June 3, 2014, Valneva SE's market cap has increased from $450.94M to $979.42M, an increase of 117.19%. That is a compound annual growth rate of 7.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 979.42M | 169.44% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 239.54% |
| Dec 31, 2020 | 862.29M | 228.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |